We believe that collaboration with medical community is the key to identifying patients’ needs, developing innovative medicines and enhancing the quality of health education.
HRA Pharma discloses transfers of value to healthcare professionals and organizations in compliance with local regulations and/or an industry code of conduct (when applicable)
Below are the links to the Transparency reports for the countries where HRA Pharma has transfers of values to disclose.
The Transparency reports include the transfers of values from HRA Pharma to HCPs and HCOs, as described in Professional Codes and applicable laws in each country.
In some countries disclosure reports are published on central platforms. In these cases you will be directed to a third party website.